Bungalon, Ana L.
HRN: 21-59-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/18/2022
07/20/2022
IVT
500mg
Q8
Post Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes